These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 12716219)

  • 1. Neurocardiogenic syncope in children : current concepts in diagnosis and management.
    Massin M
    Paediatr Drugs; 2003; 5(5):327-34. PubMed ID: 12716219
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical practice. Neurocardiogenic syncope.
    Grubb BP
    N Engl J Med; 2005 Mar; 352(10):1004-10. PubMed ID: 15758011
    [No Abstract]   [Full Text] [Related]  

  • 3. Syncope: pathophysiology, diagnosis, and pharmacotherapy.
    Lazarus JC; Mauro VF
    Ann Pharmacother; 1996 Sep; 30(9):994-1005. PubMed ID: 8876862
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Management of vasovagal syncope.
    Atiga WL; Rowe P; Calkins H
    J Cardiovasc Electrophysiol; 1999 Jun; 10(6):874-86. PubMed ID: 10376927
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Strategy for the management of vasovagal syncope.
    Bloomfield DM
    Drugs Aging; 2002; 19(3):179-202. PubMed ID: 12027777
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Medical therapy of neurocardiogenic syncope.
    Cadman CS
    Cardiol Clin; 2001 May; 19(2):203-13, v. PubMed ID: 11407106
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pathophysiology and management of neurocardiogenic syncope.
    Nair N; Padder FA; Kantharia BK
    Am J Manag Care; 2003 Apr; 9(4):327-34; quiz 335-6. PubMed ID: 12703677
    [TBL] [Abstract][Full Text] [Related]  

  • 8. What can I do when first-line measures are not enough for vasovagal syncope?
    Hutt Centeno E; Mayuga KA
    Cleve Clin J Med; 2018 Dec; 85(12):920-922. PubMed ID: 30526751
    [No Abstract]   [Full Text] [Related]  

  • 9. Neurocardiogenic syncope: latest pharmacological therapies.
    Chen LY; Shen WK
    Expert Opin Pharmacother; 2006 Jun; 7(9):1151-62. PubMed ID: 16732702
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dysautonomia and neurocardiogenic syncope.
    McLeod KA
    Curr Opin Cardiol; 2001 Mar; 16(2):92-6. PubMed ID: 11224639
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of neurally mediated reflex syncope.
    Guzman JC; Armaganijan LV; Morillo CA
    Cardiol Clin; 2013 Feb; 31(1):123-9. PubMed ID: 23217693
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence-based treatment for vasovagal syncope.
    Kuriachan V; Sheldon RS; Platonov M
    Heart Rhythm; 2008 Nov; 5(11):1609-14. PubMed ID: 18984541
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacologic approaches to therapy for vasovagal syncope.
    Calkins H
    Am J Cardiol; 1999 Oct; 84(8A):20Q-25Q. PubMed ID: 10568557
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of Outcomes with Midodrine and Fludrocortisone for Objective Recurrence in Treating Syncope (COMFORTS trial): Rationale and design for a multi-center randomized controlled trial.
    Aminorroaya A; Tavolinejad H; Sadeghian S; Jalali A; Alaeddini F; Emkanjoo Z; Mollazadeh R; Bozorgi A; Oraii S; Kiarsi M; Shahabi J; Akbarzadeh MA; Rahimi B; Joharimoghadam A; Mohsenizade A; Mohammadi R; Oraii A; Ariannejad H; Apakuppakul S; Ngarmukos T; Tajdini M
    Am Heart J; 2021 Jul; 237():5-12. PubMed ID: 33689731
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Management strategies for recurrent vasovagal syncope.
    Vaddadi G; Corcoran SJ; Esler M
    Intern Med J; 2010 Aug; 40(8):554-60. PubMed ID: 20718882
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vasovagal syncope: an update on the latest pharmacological therapies.
    Schleifer JW; Shen WK
    Expert Opin Pharmacother; 2015 Mar; 16(4):501-13. PubMed ID: 25534874
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current concepts in the evaluation and management of syncope.
    Kuriachan V; Sheldon RS
    Curr Cardiol Rep; 2008 Sep; 10(5):384-90. PubMed ID: 18715535
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacotherapy of neurally mediated syncope.
    Benditt DG; Fahy GJ; Lurie KG; Sakaguchi S; Fabian W; Samniah N
    Circulation; 1999 Sep; 100(11):1242-8. PubMed ID: 10484547
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of paroxetine hydrochloride, a selective serotonin reuptake inhibitor, on refractory vasovagal syncope: a randomized, double-blind, placebo-controlled study.
    Di Girolamo E; Di Iorio C; Sabatini P; Leonzio L; Barbone C; Barsotti A
    J Am Coll Cardiol; 1999 Apr; 33(5):1227-30. PubMed ID: 10193720
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of midodrine hydrochloride in neurocardiogenic syncope refractory to standard therapy.
    Sra J; Maglio C; Biehl M; Dhala A; Blanck Z; Deshpande S; Jazayeri MR; Akhtar M
    J Cardiovasc Electrophysiol; 1997 Jan; 8(1):42-6. PubMed ID: 9116967
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.